Complex Gene−Chemical Interactions: Hepatic Uroporphyria As a Paradigm
The DOI matches its Crossref record; 166 of the 167 references it cites were found in a registry or an index.
Abstract
Many toxicological disorders, in common with numerous human diseases, are probably the consequence of multigene interactions with a variety of chemical and physiological factors. The importance of genetic factors may not be obvious initially from association studies because of their complexity and variable penetrance. The human disease, porphyria cutanea tarda (PCT), is a skin disease caused by the photosensitizing action of porphyrins arising secondary to the decreased activity of an enzyme of heme biosynthesis, uroporphyrinogen decarboxylase (UROD), in the liver. It is triggered by idiosyncratic hepatic interaction between genetic factors and chemicals such as alcohol, estrogenic drugs, and polyhalogenated aromatics. PCT and its animal models are known collectively as the hepatic uroporphyrias. There is strong evidence for the participation of iron in the pathogenesis of these conditions. Mouse models have been used to explore the relative importance of a variety of agents such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), alcohol, and iron in the development of uroporphyria and to elucidate the mechanism of the depression of hepatic UROD activity. Mutations of the UROD and hemochromatosis (HFE) genes are genetic factors in some PCT patients which can be mimicked in mice heterozygous for the Hfe and Urod null genes. Association studies of uroporphyria induced by TCDD or hexachlorobenzene with DNA markers in mouse intercrosses have shown the participation of other, unknown, genetic factors in addition to the strong influence of the Ahr gene. The pathogenesis of hepatic uroporphyrias exemplifies the complexity of the interactions between chemical and genetic factors that can contribute to the hepatotoxicity of chemicals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there is little doubt that iron is important in the toxicity of a wide variety of polyhalogenated aromatics (Smith and Chernova 2009; Smith and Elder 2010), including hexachlorobenzene (ChEBI 5692) (Franklin et al. 2005)”
Citations
Cites
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050
Replication validity of genetic association studies
Ioannidis, J. P. A., Ntzani, E. E., Trikalinos, T. A., & Contopoulos-Ioannidis, D. G. (2001) · Nature Genetics · doi:10.1038/ng749 · Cited by 1,832
A marker for Stevens–Johnson syndrome
Chung, W.-H., Hung, S.-I., Hong, H.-S., Hsih, M.-S., Yang, L.-C., Ho, H.-C., Wu, J.-Y., & Chen, Y.-T. (2004) · Nature · doi:10.1038/428486a · Cited by 1,753
Hentze, M. W., Muckenthaler, M. U., & Andrews, N. C. (2004) · Cell · doi:10.1016/s0092-8674(04)00343-5 · Cited by 1,736
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
Gene–environment interactions in human diseases
Hunter, D. J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1578 · Cited by 1,132
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
Navarro, V. J., & Senior, J. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052270 · Cited by 811
MOLECULAR MECHANISMS OF GENETIC POLYMORPHISMS OF DRUG METABOLISM
Meyer, U. A., & Zanger, U. M. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.269 · Cited by 549
Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment
Ingelman-Sundberg, M., Oscarson, M., & McLellan, R. A. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01363-2 · Cited by 539
High-Resolution Whole-Genome Association Study of Parkinson Disease
Maraganore, D. M., de Andrade, M., Lesnick, T. G., Strain, K. J., Farrer, M. J., Rocca, W. A., Pant, P. V. K., Frazer, K. A., Cox, D. R., & Ballinger, D. G. (2005) · The American Journal of Human Genetics · doi:10.1086/496902 · Cited by 508
α-FETOPROTEIN IN INDIAN CHILDHOOD CIRRHOSIS
Agarwal, S. S., Mehta, S. K., & Bajpai, P. C. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91619-5 · Cited by 407
Genetic susceptibility to adverse drug reactions
Pirmohamed, M., & Park, B. K. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01717-x · Cited by 328
Role of Metabolism in Drug-Induced Idiosyncratic Hepatotoxicity
Walgren, J. L., Mitchell, M. D., & Thompson, D. C. (2005) · Critical Reviews in Toxicology · doi:10.1080/10408440590935620 · Cited by 322
Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda
Roberts, A. G., Whatley, S. D., Morgan, R. R., Worwood, M., & Elder, G. H. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09436-6 · Cited by 316
Self-citationWhatley, S. D., Ducamp, S., Gouya, L., Grandchamp, B., Beaumont, C., Badminton, M. N., Elder, G. H., Holme, S. A., Anstey, A. V., Parker, M., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.08.003 · Cited by 293
Self-citationCam, C., & Nigogosyan, G. (1963) · JAMA · doi:10.1001/jama.1963.03700020038009 · Cited by 288
Elder, G. (1998) · Seminars in Liver Disease · doi:10.1055/s-2007-1007142 · Cited by 267
Self-citationPORPHYRIN BIOSYNTHESIS IN ERYTHROCYTES
Mauzerall, D., & Granick, S. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77427-4 · Cited by 261
Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer
Druesne-Pecollo, N., Tehard, B., Mallet, Y., Gerber, M., Norat, T., Hercberg, S., & Latino-Martel, P. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70019-1 · Cited by 253
Genomic Priorities and Public Health
Merikangas, K. R., & Risch, N. (2003) · Science · doi:10.1126/science.1091468 · Cited by 250
Grossman, M. E., Bickers, D. R., Poh-Fitzpatrick, M. B., Deleo, V. A., & Harber, L. C. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90403-0 · Cited by 244
Acquired Porphyria in Man and Rat due to Hexachlorobenzene Intoxication
OCKNER, R. K., & SCHMID, R. (1961) · Nature · doi:10.1038/189499a0 · Cited by 233
Schmid, R. (1960) · New England Journal of Medicine · doi:10.1056/nejm196008252630807 · Cited by 222
HFE mutations, iron deficiency and overload in 10 500 blood donors
Jackson, H. A., Carter, K., Darke, C., Guttridge, M. G., Ravine, D., Hutton, R. D., Napier, J. A., & Worwood, M. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02949.x · Cited by 218
Industrially Acquired Porphyria
BLEIBERG, J. (1964) · Archives of Dermatology · doi:10.1001/archderm.1964.01590300021006 · Cited by 211
Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda
Bulaj, Z. J., Phillips, J. D., Ajioka, R. S., Franklin, M. R., Griffen, L. M., Guinee, D. J., Edwards, C. Q., & Kushner, J. P. (2000) · Blood · doi:10.1182/blood.v95.5.1565.005k42_1565_1571 · Cited by 210
Nebert, D. W., Zhang, G., & Vesell, E. S. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530801952864 · Cited by 181
Nervous and Biochemical Disturbances Following Hexachlorobenzene Intoxication
De MATTEIS, F., PRIOR, B. E., & RIMINGTON, C. (1961) · Nature · doi:10.1038/191363a0 · Cited by 178
Pharmacogenetics of Gilbert‘s Syndrome
Strassburg, C. P. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.6.703 · Cited by 165
A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda
Phillips, J. D., Bergonia, H. A., Reilly, C. A., Franklin, M. R., & Kushner, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700547104 · Cited by 160
Andrade, R. J., Lucena, I. M., Alonso, A., García-Cort'es, M., García-Ruiz, E., Benitez, R., Fernández, C. M., Pelaez, G., Romero, M., Corpas, R., et al. (2004) · Hepatology · doi:10.1002/hep.20215 · Cited by 153
The Development and Prognosis of Chronic Intoxication by Tetrachlordibenzo-p-dioxin in Men
PAZDEROVA-VEJLUPKOVÁ, J., NEMCOVA, M., PÍCKOVA, J., JIRÁSEK, L., & LUKÁŠ, E. (1981) · Archives of Environmental Health: An International Journal · doi:10.1080/00039896.1981.10667598 · Cited by 153
Do We Need Genomic Research for the Prevention of Common Diseases with Environmental Causes?
Khoury, M. J., Davis, R., Gwinn, M., Lindegren, M. L., & Yoon, P. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi113 · Cited by 149
Macrocyclic intermediates in the biosynthesis of porphyrins
Jackson, A. H., Sancovich, H. A., Ferramola, A. M., Evans, N., Games, D. E., Matlin, S. A., Elder, G. H., & Smith, S. G. (1976) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1976.0009 · Cited by 141
Self-citationGilbert's disease and atazanavir: From phenotype to UDP-glucuronosyltransferase haplotype
Lankisch, T. O., Möbius, U., Wehmeier, M., Behrens, G. M. N., Manns, M. P., Schmidt, R. E., & Strassburg, C. P. (2006) · Hepatology · doi:10.1002/hep.21361 · Cited by 139
IMMUNOREACTIVE UROPORPHYRINOGEN DECARBOXYLASE IN THE LIVER IN PORPHYRIA CUTANEA TARDA
Elder, G. H., Salamanca, R. D., Urquhart, A. J., Munoz, J., & Bonkovsky, H. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90287-9 · Cited by 135
Self-citationCrystal structure of human uroporphyrinogen decarboxylase
Whitby, F. G., Phillips, J. D., Kushner, J. P., & Hill, C. P. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2463 · Cited by 129
Uno, S., Dalton, T. P., Sinclair, P. R., Gorman, N., Wang, B., Smith, A. G., Miller, M. L., Shertzer, H. G., & Nebert, D. W. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.01.014 · Cited by 124
Egger, N. G., Goeger, D. E., Payne, D. A., Miskovsky, E. P., Weinman, S. A., & Anderson, K. E. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1013746828074 · Cited by 113
Landi, S. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.12.001 · Cited by 113
Environmental health and genomics: visions and implications
Olden, K., & Wilson, S. H. (2000) · Nature Reviews Genetics · doi:10.1038/35038586 · Cited by 112
Iron Deficiency Prevents Liver Toxicity of 2,3,7,8-Tetrachlorodibenzo- p -Dioxin
Sweeny, G. D., Jones, K. G., Cole, F. M., Basford, D., & Krestynski, F. (1979) · Science · doi:10.1126/science.432648 · Cited by 112
Smith, A. G., & Francis, J. E. (1983) · Biochemical Journal · doi:10.1042/bj2140909 · Cited by 107
Self-citationMolecular aspects of the inherited porphyrias
Sassa, S., & Kappas, A. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00618.x · Cited by 106
Jones, K. G., & Sweeney, G. D. (1980) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(80)90379-8 · Cited by 105
Porphyria Cutanea Tarda and Hepatocellular Carcinoma
Salata, H., Cortés, J. M. S., de Salamanca, R. E., Oliva, H., Castro, A., Kusak, E., Carréño, V., & Guio, C. H. (1985) · Journal of Hepatology · doi:10.1016/s0168-8278(85)80746-7 · Cited by 96
Cutaneous manifestations of tetrachlorodibenzo-p-dioxin in children and adolescents
Caputo, R., Monti, M., Ermacora, E., Carminati, G., Gelmetti, C., Gianotti, R., Gianni, E., & Puccinelli, V. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)70238-8 · Cited by 96
Smith, A. G., Clothier, B., Carthew, P., Childs, N. L., Sinclair, P. R., Nebert, D. W., & Dalton, T. P. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9167 · Cited by 95
Self-citationAdvances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead
Nebert, D. W., & Vesell, E. S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.031 · Cited by 91
de Viale, L. C. S. M., Viale, A. A., Nacht, S., & Grinstein, M. (1970) · Clinica Chimica Acta · doi:10.1016/0009-8981(70)90155-5 · Cited by 88
SINCLAIR, R. P., GORMAN, N., DALTON, T., WALTON, S. H., BEMENT, J. W., SINCLAIR, F. J., SMITH, G. A., & NEBERT, W. D. (1998) · Biochemical Journal · doi:10.1042/bj3300149 · Cited by 85
Molecular mechanisms of dominant expression in porphyria
Badminton, M. N., & Elder, G. H. (2005) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-005-8050-3 · Cited by 85
Self-citationSmith, A. G., Francis, J. E., Dinsdale, D. D., Manson, M. M., & Cabral, J. R. P. (1985) · Carcinogenesis · doi:10.1093/carcin/6.4.631 · Cited by 81
Self-citationFracanzani, A. L., Taioli, E., Sampietro, M., Fatta, E., Bertelli, C., Fiorelli, G., & Fargion, S. R. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00160-x · Cited by 81
Bonkovsky, H. L., & Lambrecht, R. W. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70116-1 · Cited by 79
Brady, J. J., Roberts, A., Morgan, R. R., Whatley, S. D., Rowlands, G. L., Watson, R., Elder, G. H., Jackson, H. A., Worwood, M., Darby, C., et al. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00148.x · Cited by 78
Self-citationExperimental porphyria in rats induced by chlorinated benzenes
Rimington, C., & Ziegler, G. (1963) · Biochemical Pharmacology · doi:10.1016/0006-2952(63)90208-9 · Cited by 71
R/qtlDesign: inbred line cross experimental design
Sen, Ś., Satagopan, J. M., Broman, K. W., & Churchill, G. A. (2007) · Mammalian Genome · doi:10.1007/s00335-006-0090-y · Cited by 70
A mouse model of familial porphyria cutanea tarda
Phillips, J. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011481398 · Cited by 69
Greig, J. B., Francis, J. E., Kay, S. J. E., Lovell, D. P., & Smith, A. G. (1984) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(84)90265-5 · Cited by 69
Self-citationHereditary Determinants of Human Hypertension
Shih, P.-A. B., & O’Connor, D. T. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.090480 · Cited by 69
Porphyria Caused by Hexachlorobenzene and Other Polyhalogenated Aromatic Hydrocarbons
Elder, G. H. (1978) · Springer eBooks · doi:10.1007/978-3-642-66763-3_6 · Cited by 66
Self-citationROCCHI, E., GIBERTINI, P., CASSANELLI, M., PIETRANGELO, A., BORGHI, A., PANTALEONI, M., JENSEN, J., & VENTURA, E. (1986) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1986.tb04071.x · Cited by 66
Smith, A. G., Clothier, B., Robinson, S., Scullion, M. J., Carthew, P., Edwards, R., Luo, J., Lim, C. K., & Toledano, M. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.1.52 · Cited by 65
Self-citationPorphyrin Metabolism in Experimental Hepatic Siderosis in the Rat
Taljaard, J. J. F., SHANLEY, B. C., Deppe, W. M., & Joubert, S. M. (1972) · British Journal of Haematology · doi:10.1111/j.1365-2141.1972.tb07086.x · Cited by 64
Elder, G. H., & Sheppard, D. M. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91573-x · Cited by 63
Self-citationSmith, A. G., & Francis, J. E. (1987) · Biochemical Journal · doi:10.1042/bj2460221 · Cited by 62
Self-citationSmith, A. G., Cabral, J. R. P., Carthew, P., Francis, J. E., & Manson, M. M. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430325 · Cited by 62
Self-citationGoldstein, J. A., Hickman, P., Burse, V. W., & Bergman, H. B. (1975) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(75)90111-8 · Cited by 61
CYP1A2 Is Essential in Murine Uroporphyria Caused by Hexachlorobenzene and Iron
Sinclair, P. R., Gorman, N., Walton, H. S., Bement, W. J., Dalton, T. P., Sinclair, J. F., Smith, A. G., & Nebert, D. W. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8832 · Cited by 58
Self-citationSmith, A. G., & Matteis, F. D. (1990) · Xenobiotica · doi:10.3109/00498259009046902 · Cited by 58
Self-citationIn vitro inhibitory effect on porphyrinogen carboxylyase of liver extracts from tcdd treated mice
Cantoni, L., Fiume, D. D., Rizzardini, M., & Ruggieri, R. (1984) · Toxicology Letters · doi:10.1016/0378-4274(84)90149-8 · Cited by 57
Francis, J. E., & Smith, A. G. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80449-6 · Cited by 55
Self-citationThe role of iron in the toxicity of 2,3,7,8-tetrachlorodibenzo-(p)-dioxin (TCDD)
Jones, K. G., Cole, F. M., & Sweeney, G. D. (1981) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(81)90009-0 · Cited by 55
Siersema, P. D., Rademakers, L. H. P. M., Cleton, M. I., ten Kate, F. J. W., de Bruijn, W. C., Marx, J. J. M., & Wilson, J. H. P. (1995) · Journal of Hepatology · doi:10.1016/s0168-8278(95)80004-2 · Cited by 55
Magness, S. T., Maeda, N., & Brenner, D. A. (2002) · Blood · doi:10.1182/blood-2001-12-0283 · Cited by 55
Smith, A. G., Francis, J. E., & Carthew, P. (1990) · Carcinogenesis · doi:10.1093/carcin/11.3.437 · Cited by 55
Self-citationAssociation between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda
Christiansen, L., Bygum, A., Jensen, A., Thomsen, K., Brandrup, F., Hørder, M., & Petersen, N. E. (2000) · Human Genetics · doi:10.1007/s004390000415 · Cited by 53
Porphyrin levels in plasma and erythrocytes of chronic hemodialysis patients
Poh‐Fitzpatrick, M. B., Sosin, A. E., & Bemis, J. A. (1982) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(82)80016-9 · Cited by 53
The involvement of iron and lipid peroxidation in the pathogenesis of hcb induced porphyria
Alleman, M. A., Koster, J. F., Wilson, J. H. P., Edixhoven-Bosdijk, A., Slee, R. G., Kroos, M. J., & van Eijk, H. G. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90118-2 · Cited by 52
THE EFFECT OF PHLEBOTOMY THERAPY IN PORPHYRIA CUTANEA TARDA
Lundvall, O. (1971) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1971.tb04337.x · Cited by 52
Genetic variation of iron-induced uroporphyria in mice
Smith, A. G., & Francis, J. E. (1993) · Biochemical Journal · doi:10.1042/bj2910029 · Cited by 50
Self-citationUroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid
Urquhart, A., Elder, G. H., Roberts, A., Lambrecht, R., Sinclair, P. R., Bement, W. J., Gorman, N., & Sinclair, J. A. (1988) · Biochemical Journal · doi:10.1042/bj2530357 · Cited by 50
Self-citationSmith, A. G., Francis, J. E., Kay, S. J. E., & Greig, J. B. (1981) · Biochemical Pharmacology · doi:10.1016/0006-2952(81)90421-4 · Cited by 50
Self-citationBulaj, Z. J., Franklin, M. R., Phillips, J. D., Miller, K. L., Bergonia, H. A., Ajioka, R. S., Griffen, L. M., Guinee, D. J., Edwards, C. Q., & Kushner, J. P. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2000.111024 · Cited by 50
Familial and Sporadic Porphyria Cutanea Tarda: Characterization and Diagnostic Strategies
Aarsand, A. K., Boman, H., & Sandberg, S. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.117432 · Cited by 49
Matteis, F. D. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13332-4 · Cited by 49
Goldstein, J. A., Linko, P., & Bergman, H. B. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90388-4 · Cited by 48
Sunyer, J., Herrero, C., Ozalla, D., Sala, M., Ribas‐Fitó, N., Grimalt, J. O., & Basagaña, X. (2002) · Environmental Health · doi:10.1186/1476-069x-1-1 · Cited by 46
Smith, A. G., Francis, J. E., Kay, S. J. E., Greig, J. B., & Stewart, F. P. (1986) · Biochemical Journal · doi:10.1042/bj2380871 · Cited by 46
Self-citationCantoni, L., Salmona, M., & Rizzardini, M. (1981) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(81)90275-1 · Cited by 46
Smith, A. G., Cabral, J. R. P., & Matteis, F. D. (1979) · Chemico-Biological Interactions · doi:10.1016/0009-2797(79)90138-8 · Cited by 46
Self-citation[Chloracne, porphyria cutanea tarda, and other poisonings due to the herbicides].
Jirásek, L., Kalenský, J., Kubec, K., Pazderova, J., & Lukás, E. (1976) · PubMed · Cited by 46
Francis, J. E., & Smith, A. G. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90683-8 · Cited by 45
Self-citationDown-regulation of hepcidin in porphyria cutanea tarda
Ajioka, R. S., Phillips, J. D., Weiss, R. B., Dunn, D. M., Smit, M. W., Proll, S. C., Katze, M. G., & Kushner, J. P. (2008) · Blood · doi:10.1182/blood-2008-02-138222 · Cited by 45
Experimental porphyrias as models for human hepatic porphyrias.
Matteis, F. D., & Stonard, M. D. (1977) · PubMed · Cited by 44
Characterization and crystallization of human uroporphyrinogen decarboxylase
Phillips, J. D., Kushner, J. P., Whitby, F. G., & Hill, C. P. (1997) · Protein Science · doi:10.1002/pro.5560060624 · Cited by 43
Hepatic siderosis and porphyria cutanea tarda: relation of iron excess to the metabolic defect.
Felsher, B. F., & Kushner, J. P. (1977) · PubMed · Cited by 43
Enhancement by iron of hepatic neoplasia in rats caused by hexachlorobenzene
Smith, A. G., Carthew, P., Francis, J. E., Cabral, J. R. P., & Manson, M. M. (1993) · Carcinogenesis · doi:10.1093/carcin/14.7.1381 · Cited by 41
Self-citationTHE THERAPEUTIC EFFECT OF ADENOSINE-5-MONOPHOSPHORIC ACID IN PORPHYRIA
Gajdos, A., & Török, M. G. (1961) · The Lancet · doi:10.1016/s0140-6736(61)90463-9 · Cited by 40
Gilbert??s Syndrome and Drug Metabolism
MacKlon, A. F., Savage, R. L., & Rawlins, M. D. (1979) · Clinical Pharmacokinetics · doi:10.2165/00003088-197904030-00004 · Cited by 40
Alcohol intake and porphyria cutanea tarda
Elder, G. H. (1999) · Clinics in Dermatology · doi:10.1016/s0738-081x(99)00029-2 · Cited by 38
Self-citationBádenas, C., To‐Figueras, J., Phillips, J., Warby, C., Muñoz, C., & Herrero, C. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01153.x · Cited by 38
Turkish Epidemic Hexachlorobenzene Porphyria A 30‐Year Study
PETERS, H., Cripps, D. J., Göçmen, A., Bryan, G. T., Ertürk, E., & Morris, C. R. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb48773.x · Cited by 37
Clothier, B., Robinson, S., Akhtar, R. A., Francis, J. E., Peters, T. J., Raja, K. B., & Smith, A. G. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00306-8 · Cited by 37
Self-citationEffects of a polybrominated biphenyl mixture in the rat and mouse
Gupta, B. N., McConnell, E. E., Moore, J. A., & Haseman, J. K. (1983) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(83)90351-4 · Cited by 36
Familial and sporadic porphyria cutanea: two different diseases
de Verneuil, H., NORDMANN, Y., Phung, N., Grandchamp, B., Aïtken, G., Grelier, M., & Noiré, J. (1978) · International Journal of Biochemistry · doi:10.1016/0020-711x(78)90072-1 · Cited by 35
PORPHYRINS IN URINE AS AN INDICATION OF EXPOSURE TO CHLORINATED HYDROCARBONS
Strik, J. J. T. W. A. (1979) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1979.tb56613.x · Cited by 35
Smith, A. G., Francis, J. E., Green, J. A., Greig, J. B., Wolf, C. R., & Manson, M. M. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90236-e · Cited by 34
Self-citationMylchreest, E., & Charbonneau, M. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8157 · Cited by 34
Robinson, S. W., Clothier, B., Akhtar, R. A., Yang, A. L., Latour, I., Ijperen, C. V., Festing, M. F. W., & Smith, A. G. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.3.674 · Cited by 33
Self-citationConsiderations for Genomewide Association Studies in Parkinson Disease
Myers, R. H. (2006) · The American Journal of Human Genetics · doi:10.1086/504730 · Cited by 33
Porphyrin Metabolism in Experimental Hepatic Siderosis in the Rat
Taljaard, J. J. F., SHANLEY, B. C., Deppe, W. M., & Joubert, S. M. (1972) · British Journal of Haematology · doi:10.1111/j.1365-2141.1972.tb07093.x · Cited by 33
Rowley, B., & Sweeney, G. D. (1984) · Canadian Journal of Biochemistry and Cell Biology · doi:10.1139/o84-165 · Cited by 31
Uroporphyria induced by 5-aminolaevulinic acid alone in ahrd SWR mice
Constantin, D., Francis, J. E., Akhtar, R. A., Clothier, B., & Smith, A. G. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00475-3 · Cited by 31
Self-citationUroporphyria in mice: Thresholds for hepatic CYP1A2 and iron
Gorman, N., Ross, K. L., Walton, H. S., Bement, W. J., Szakacs, J. G., Gerhard, G. S., Dalton, T. P., Nebert, D. W., Eisenstein, R. S., Sinclair, J. F., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.32487 · Cited by 31
Chloracne Caused by Ingestion of Olive Oil Contaminated with PCDDs and PCDFs
Rodríguez‐Pichardo, A., Camacho, F., Rappe, C., Hansson, M., Smith, A. G., & Greig, J. B. (1991) · Human & Experimental Toxicology · doi:10.1177/096032719101000503 · Cited by 30
Self-citationDavies, R., Clothier, B., Robinson, S. W., Edwards, R. E., Greaves, P., Luo, J., Gant, T. W., Chernova, T., & Smith, A. G. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700176r · Cited by 29
Self-citationEffect of desferrioxamine on the development of hexachlorobenzene-induced porphyria
de Calmanovici, R. W., Billi, S. C., Sldonatti, C. A., & de Viale, L. C. S. M. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90467-3 · Cited by 28
Εvangelou, Ε., Maraganore, D. M., Annesi, G., Brighina, L., Brice, A., Elbaz, A., Ferrarese, C., Hadjigeorgiou, G. M., Krüger, R., Lambert, J., et al. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30980 · Cited by 27
Baravalle, E., & Prìeto, J. (1983) · Gastroenterology · doi:10.1016/0016-5085(83)90369-4 · Cited by 26
Gorman, N., Walton, H. S., Bement, W. J., Honsinger, C. P., Szakacs, J. G., Sinclair, J. F., & Sinclair, P. R. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00088-x · Cited by 26
Smith, A. G., & Francis, J. E. (1981) · Biochemical Pharmacology · doi:10.1016/0006-2952(81)90022-8 · Cited by 26
Self-citationChemical Porphyria in Japanese Quail
Strik, J. J. T. W. A. (2017) · Enzyme · doi:10.1159/000459383 · Cited by 26
Uroporphyria produced in mice by iron and 5-aminolevulinic acid
Deam, S., & Elder, G. H. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90144-t · Cited by 24
Self-citationIncrease in urinary porphyrin excretion in workers exposed to polychlorinated biphenyls
Colombi, A., Maroni, M., Ferioli, A., Castoldi, M., Jun, L. K., Valla, C., & Foà, V. (1982) · Journal of Applied Toxicology · doi:10.1002/jat.2550020302 · Cited by 23
The genetics of cardiovascular disease
Delles, C., McBride, M., Padmanabhan, S., & Dominiczak, A. F. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.07.010 · Cited by 23
Blekkenhorst, G., Day, R. S., & Eales, L. (1980) · International Journal of Biochemistry · doi:10.1016/0020-711x(80)90204-9 · Cited by 23
Chromosomal linkage analysis of porphyria in mice induced by hexachlorobenzene-iron synergism
Akhtar, R. A., & Smith, A. G. (1998) · Pharmacogenetics · doi:10.1097/00008571-199812000-00005 · Cited by 22
Self-citationChemical (HCB) porphyria: Effect of removal of sex organs in the rat
Grant, D. L., Shields, J. B., & Villeneuve, D. C. (1975) · Bulletin of Environmental Contamination and Toxicology · doi:10.1007/bf01705507 · Cited by 21
Phillips, J. D., Warby, C. A., Whitby, F. G., Kushner, J. P., & Hill, C. P. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.04.013 · Cited by 21
HEXACHLOROBENZENE PESTICIDES AND PORPHYRIA
Morley, A. M., Geary, D. L., & Harben, F. (1973) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb119763.x · Cited by 20
Multiple polymorphic loci determine basal hepatic and splenic iron status in mice
Grant, G. R., Robinson, S. W., Edwards, R., Clothier, B., Davies, R., Judah, D. J., Broman, K. W., & Smith, A. G. (2006) · Hepatology · doi:10.1002/hep.21233 · Cited by 20
Self-citationPorphyrin Status in Aluminum Foundry Workers Exposed to Hexachlorobenzene and Octachlorostyrene
Seldén, A. I., Flodérus, Y., Bodin, L. S., Westberg, H., & Thunell, S. (1999) · Archives of Environmental Health An International Journal · doi:10.1080/00039899909602482 · Cited by 20
Sinclair, P. R., Gorman, N., Walton, H. S., Bement, W. J., Sinclair, J. F., Gerhard, G. S., Szakacs, J. G., Andrews, N. C., & Levy, J. E. (2001) · Hepatology · doi:10.1053/jhep.2001.21409 · Cited by 20
Toxicity of Polychlorinated Biphenyl with Special Reference to Porphyrin Metabolism
Sano, S., Kawanishi, S., & Seki, Y. (1985) · Environmental Health Perspectives · doi:10.2307/3429886 · Cited by 19
Urinary Porphyrin Excretion in Children is Associated with Exposure to Organochlorine Compounds
Sunyer, J., Álvarez‐Pedrerol, M., To‐Figueras, J., Ribas‐Fitó, N., Grimalt, J. O., & Herrero, C. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11354 · Cited by 19
Further Discussion Concerning Porphyria Cutanea Tarda and TCDD Exposure
Jones, R. E., & Chelsky, M. (1986) · Archives of Environmental Health An International Journal · doi:10.1080/00039896.1986.9937417 · Cited by 18
Investigations on the role of free radical processes in hexachlorobenzene‐induced porphyria in mice
Rizzardini, M., Graziani, A., Carugo, C., & Cantoni, L. (1988) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.2570030105 · Cited by 18
Uroporphyria caused by ethanol in Hfe (−/−) mice as a model for porphyria cutanea tarda
Sinclair, P. R., Gorman, N., Trask, H. W., Bement, W. J., Szakacs, J. G., Elder, G. H., Balestra, D. J., Sinclair, J. F., & Gerhard, G. S. (2003) · Hepatology · doi:10.1053/jhep.2003.50034 · Cited by 18
Self-citationUroporphyrinogen decarboxylase gene mutations in Danish patients with porphyria cutanea tarda
L. Christiansen, A. B. (2000) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655100448365 · Cited by 18
Evaluation of porphyria cutanea tarda in U.S. workers exposed to 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin
Calvert, G. M., Sweeney, M. H., Fingerhut, M. A., Hornung, R., & Halperin, W. E. (1994) · American Journal of Industrial Medicine · doi:10.1002/ajim.4700250410 · Cited by 16
Gorman, N., Zaharia, A., Trask, H. S., Szakacs, J. G., Jacobs, N. J., Jacobs, J. M., Balestra, D. J., Sinclair, J. F., & Sinclair, P. R. (2007) · Hepatology · doi:10.1002/hep.21903 · Cited by 15
Free radicals in the pathogenesis of liver injury
Ward, P. A. (1990) · Hepatology · doi:10.1002/hep.1840120635 · Cited by 15
Koss, G., Meyer-Rogge, D., Seubert, S., Seubert, A., & Losekam, M. (1993) · Archives of Toxicology · doi:10.1007/bf01974073 · Cited by 14
Greaves, P., Clothier, B., Davies, R., Higginson, F. M., Edwards, R., Dalton, T. P., Nebert, D. W., & Smith, A. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.136 · Cited by 14
Self-citationRecent advances in the genetics of diabetes
Pearson, E. R. (2008) · Primary care diabetes · doi:10.1016/j.pcd.2007.12.005 · Cited by 14
Gorman, N., Zaharia, A., Trask, H. S., Szakacs, J. G., Jacobs, N. J., Jacobs, J. M., Balestra, D. J., Sinclair, J. F., & Sinclair, P. R. (2006) · Hepatology · doi:10.1002/hep.21474 · Cited by 13
Danton, M., & Lim, C. K. (2007) · Biomedical Chromatography · doi:10.1002/bmc.790 · Cited by 13
Ippen, H. (1960) · PubMed · doi:10.1007/bf01483617 · Cited by 13
Porphyria Cutanea Tarda and HLA-Linked Hemochromatosis
Elder, G. H. (1985) · Gastroenterology · doi:10.1016/s0016-5085(85)80094-9 · Cited by 12
Self-citationGreig, J. B., Francis, J. E., Kay, S. J. E., Lister, T., Ray, D. E., Seawright, A. A., & Smith, A. G. (1987) · Archives of Toxicology · doi:10.1007/bf00295754 · Cited by 12
Self-citationEFFECTS OF KC‐400 (POLYCHLORINATED BIPHENYLS) ON PORPHYRIN METABOLISM
Honda, T., Nonaka, S., Murayama, F., Ohgami, T., SHIMOYAMA, T., & Yoshida, H. (1983) · The Journal of Dermatology · doi:10.1111/j.1346-8138.1983.tb01135.x · Cited by 11
Pilot survey of urinary porphyrins from persons transiently exposed to a pcb transformer fire
Osterloh, J., Cone, J. E., Harrison, R., Wade, R. L., & Becker, C. (1986) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563658608995392 · Cited by 11
Genetic factors influence ethanol-induced uroporphyria in Hfe (—/—) mice
Gorman, N., Trask, H. W., Bement, W. J., Szakacs, J. G., Elder, G. H., Balestra, D. J., Jacobs, N. J., Jacobs, J. M., Sinclair, J. F., Gerhard, G. S., et al. (2004) · Hepatology · doi:10.1002/hep.20402 · Cited by 11
Self-citationFate of hexachlorobenzene in C57BL/10 mice with iron overload
Khanna, R. N., & Smith, A. G. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90209-6 · Cited by 11
Self-citationLim, C. K., Danton, M., Clothier, B., & Smith, A. G. (2006) · Chemical Research in Toxicology · doi:10.1021/tx060212v · Cited by 11
Self-citation2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced porphyria cutanea tarda among pediatric patients
Boyd, A. S., Neldner, K. H., & Naylor, M. F. (1989) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(89)80330-5 · Cited by 10
Effects of Polyhalogenated Aromatic Compounds on Porphyrin Metabolism
Hill, R. H. (1985) · Environmental Health Perspectives · doi:10.1289/ehp.8560139 · Cited by 9
Oxygenated Tetrapyrroles Produced from Porphyrinogens
Lin, W., & Timkovich, R. (1994) · Bioorganic Chemistry · doi:10.1006/bioo.1994.1006 · Cited by 9
Attenuation of polychlorinated biphenyl induced uroporphyria by iron deprivation
Franklin, M. R., Phillips, J. D., & Kushner, J. P. (2005) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2005.05.001 · Cited by 8
Smith, A. G., Francis, J. E., & Greig, J. B. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90654-9 · Cited by 8
Self-citationKadish, K. M., Smith, K. M., & Guilard, R. (2003) · Academic Press eBooks · Cited by 7
Nakano, K., Ishizuka, M., Sakamoto, K. Q., & Fujita, S. (2008) · BioMetals · doi:10.1007/s10534-008-9171-6 · Cited by 3
Research works printed but not linked: 28
- Evangelou E., 2009, Am. J. Med. Genet., Part B, 153, 220
- Anderson K. E., 2001, The Metabolic and Molecular Basis of Inherited Disease, 2991
- Thunell S., 2006, Physiol. Res., 55, S43−S66
- Jackson A. H., 1976, Philos. Trans. R. Soc., B, 273, 191
- Cam C., 1960, Ann. Dermatol. Syphiligr. (Paris), 87, 393
- Cam C., 1963, J. Am. Med. Assoc., 183, 88
- Dogramaci I., 1962, Turk. J. Pediatr., 4, 138
- Peters H. A., 1976, Fed. Proc., 35, 2400
- Dogramaci I., 1962, Turk. J. Pediatr., 4, 103
- Smith A. G., 2003, Medical Apects of Porphyrins, 169
- Smith A. G., 2009, Advances in Molecular Toxicology, 169
- Morley A., 1973, Med. J. Aust., 1, 565
- Jirasek L., 1976, Hautarzt, 27, 328
- McConnell R., 2000, Br. J. Indust. Med., 50, 699
- Chang K. J., 1980, Res. Commun. Chem. Pathol. Pharmacol., 30, 547
- Kantemir I., 1960, Turk. J. Tecr. Biyol. Derg., 20
- Sano S., 1985, Environ. Health Perspect., 59, 137
- Goldstein J. A., 1973, Res. Commun. Chem. Pathol. Pharmacol., 6, 919
- Jones K. G., 1977, Res. Commun. Chem. Pathol. Pharmacol., 17, 631
- Felsher B. F., 1977, Semin. Hematol., 14, 243
- Bach P. H., 1971, S. Afr. J. Lab. Clin. Med., 17, 75
- Siersema P., 1990, Hepatology, 12, 446
- De Matteis F., 1977, Semin. Hematol., 14, 187
- Phillips J. D., 2001, Proc. Natl. Acad. Sci. U.S.A., 98, 259, 10.1073/pnas.98.1.259 · doi:10.1073/pnas.98.1.259 · Paper page
- Dogramaci I., 1962, Turk. J. Pediatr., 4, 193
- Greig J. B., 1990, Organohalogen Compd., 1, 177
- Gorman N., 2004, Hepatology, 40, 942
- Arch D. D., 2009, Cell. Mol. Biol. (Noisy-le-Grand), 55, 46
Cited by
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“While the exact details have still not been worked out, there is little doubt that iron is important in the toxicity of a wide variety of polyhalo- genated aromatics (Smith and Chernova 2009; Smith and Elder 2010), including hexachlorobenzene (ChEBI 5692) (Franklin et al. 2005).”
BackgroundThe aryl hydrocarbon receptor (AHR), a novel regulator of human melanogenesis
Luecke, S., Backlund, M., Jux, B., Esser, C., Krutmann, J., & Rannug, A. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00762.x · Cited by 146
“Disturbance of heme biosynthesis leads to porphyria cutanea tarda-like effects that include photosensitivity and pigmentation on skin exposed to sunlight (Smith and Elder, 2010).”
BackgroundHift, R., Thunell, S., & Brun, A. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.001 · Cited by 57
“Species, sex and other factors in various combinations greatly modify susceptibility to HCB (Smith & Francis, 1981; Smith & Elder, 2010).”
BackgroundInfluentialBroad Spectrum of Hepatocyte Inclusions in Humans, Animals, and Experimental Models
Strnad, P., Nuraldeen, R., Güldiken, N., Hartmann, D., Mahajan, V., Denk, H., & Haybaeck, J. (2013) · Comprehensive physiology · doi:10.1002/cphy.c120032 · Cited by 55
The association between chemical-induced porphyria and hepatic cancer
Smith, A. G., & Foster, J. R. (2018) · Toxicology Research · doi:10.1039/c8tx00019k · Cited by 27
Self-citation
Metadata
- Authors
- Smith, A. G., & Elder, G. H.
- Affiliations
- University of Leicester (GB)
- Corresponding author
- Smith, Andrew G.
- ORCID
- Smith, Andrew G.
- Venue
- Chemical Research in Toxicology
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-01-25
- Volume
- 23
- Issue
- 4
- Pages
- 712-723
- ISSN
- 0893-228X (ISSN-L)
- 1520-5010
- OpenAlex
- W2021343367
- Cited by
- 20
- References
- 167
- Citations by year
- 2026: 2 · 2019: 2 · 2018: 2 · 2016: 1 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 1
- FWCI
- 0.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Research in Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Porphyrin Metabolism and Disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Keywords
- porphyria cutanea tarda, uroporphyrinogen decarboxylase, heme biosynthesis, porphyrins, photosensitization, iron, 2,3,7,8-tetrachlorodibenzo-p-dioxin, hexachlorobenzene, alcohol, HFE gene, hemochromatosis, hepatotoxicity, mouse model, genetic susceptibility
- MeSH terms
- Polychlorinated Dibenzodioxins, Animals, Disease Models, Animal, Hemochromatosis, Humans, Iron, Liver, Porphyrins, Uroporphyrinogen Decarboxylase, Porphyrias, Hepatic, Photosensitizing Agents, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.